Table 1.
Original reference | Belizán et al. 32 | Levine et al. 33 | Crowther et al. 34 | Villar et al. 35 | Goldberg et al. 23 | Diogenes et al. 36 | |||
Country, year | Argentina, years not stated | The United States (CPEP trial), years not stated | Australia (Australian Calcium Trial), 1992−1996 | Egypt (subset study of the WHO trial), 2001−2003 | The Gambia, 1995−2000 | Brazil, 2009−2011 | |||
Number of originally randomized (Ca/placebo), setting | 593/601, selected private hospital (309/305) | 2295/2294, selected university center (497 in all) | 227/229, five maternity hospitals | 700 in all, 200 eligible for follow‐up, one maternity center | 330/332, 16 rural villages | 43/41, adolescents | |||
Daily dose of calcium and vit. D | 2000 mg Ca | 2000 mg Ca | 1800 mg Ca | 1500 mg Ca | 1500 mg Ca | 600 mg Ca + 200 IU vit. D | |||
Calcium started | 20 weeks of gestation | 13−21 weeks of gestation | 20 weeks of gestation | 20 weeks of gestation | 20 weeks of gestation | 26 weeks of gestation | |||
Original/primary outcome | Hypertensive disorders of pregnancy | Hypertensive disorders of pregnancy | Hypertensive disorders of pregnancy and preterm delivery | Hypertensive disorders of pregnancy and preterm delivery | Hypertensive disorders of pregnancy and infant growth during the first year (secondary outcome) | Maternal bone mass and bone‐ and calcium‐related hormones during lactation | |||
Offspring outcome reference | Belizán et al. 24 | Hatton et al. 25 | Hiller et al. 26 | Abdel‐Aleem et al. 27 | Goldberg et al. 23 | Hawkesworth et al. 29 | Ward et al. 30 | Prentice et al. 31 | Diogenes et al. 28 |
n (Ca/placebo) | 257/261 |
3 months: 130/130 2 years: 35/18 |
91/88 |
6 months: 17/25 9 months: 44/39 12 months: 17/17 |
257/263 | 179/171 | 223/224 | 141/149 | 30/26 |
Offspring age | 5−9 years | 3 months, 2 years | 4−7 years | 6, 9, and 12 months | 2, 13, and 52 weeks | 5−10 years | 8−12 years | 5−10 years | 5 weeks |
Offspring outcomes | |||||||||
‐ BP | BP | BP | BP | BP | |||||
‐ Height/weight | Height/weight | Length/weight | Length/weight | Height/weight | Height/weight | Height/weight, | Length/weight | ||
‐ MUAC | MUAC | MUAC | MUAC | MUAC | |||||
‐ Skinfold thickness | TST | TST | TST | ||||||
‐ Lean mass | Lean mass | ||||||||
‐ HC | HC | HC | |||||||
‐ Other | BMI | Fetal growth | BMI, fat mass index, and trunk fat | HAZ, fat mass, and bone measurements | BMI, IGF1, IGFBP3, leptin, insulin, and Ca‐related indices | Bone measurements |
BMI, body mass index; BP, blood pressure; Ca, calcium; HAZ, height‐associated Z‐score; HC, head circumference; MUAC, mid‐upper arm circumference; TST, triceps skinfold thickness.